Medical AI in the United States
Here we discuss medical AI in the United States in terms of…
- Market Size
- Adoption Status
- Application Areas
- FDA Approval
Market Size
The medical AI market in the United States is expanding rapidly. The market size was estimated at $16.9 billion in 2023 and is projected to reach $31.4 billion by 2028, with a compound annual growth rate (CAGR) of 12.1%. This growth is driven by benefits such as improved healthcare efficiency, enhanced diagnostic accuracy, and cost reduction.
The widespread adoption of medical AI is expected to significantly improve healthcare quality and patient care.
Adoption Status
As of 2023, 76% of hospitals in the United States have implemented some form of medical AI. This indicates the growing acceptance of AI technology in healthcare settings. Additionally, the number of healthcare institutions adopting AI solutions increased by 30% year-on-year in 2022, highlighting the accelerating adoption. This increase reflects the recognition of the benefits of AI, such as improved diagnostic accuracy and operational efficiency.
The expanding adoption of medical AI underscores its reliability and utility in healthcare settings.
Application Areas
Medical AI is utilized in various fields, including image diagnosis (83%), diagnostic support (72%), treatment support (65%), drug development (58%), and care support (42%). In image diagnosis, AI analyzes medical images, contributing to the early detection of lesions and improving diagnostic accuracy. In diagnostic support, AI analyzes vast amounts of data to assist doctors in making diagnoses.
AI is also advancing in treatment support, drug development, and care support, positioning itself as a crucial tool for enhancing healthcare quality and efficiency.
FDA Approval
Since 2018, the FDA has been approving medical AI products at a rate of 1-2 per month. However, only about 20 products are currently in use on the market. This reflects the stringent regulations and safety evaluations required for AI applications in healthcare. The FDA approval process is rigorous, requiring products to meet high standards.
It is expected that more AI products will receive approval and become available in the market, further advancing the use of AI in healthcare settings.
コメント